Article
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
31 Jan 2023
Abstract excerpt
Oral squamous cell carcinoma (OSCC) is a rapidly progressive cancer that often develops resistance against DNA damage inducers, such as radiotherapy and chemotherapy, which are still the standard of care regimens for this tumor. Thus, the identification of biomarkers capable of monitoring the clinical progression of OSCC and its responsiveness to therapy is strongly required. To meet this need, here we have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
